• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    US Drug Delivery Devices Market

    ID: MRFR/HC/11870-CR
    100 Pages
    Garvit Vyas
    December 2023

    US Drug Delivery Devices Market Research Report Information By Route of Administration (Oral, Ocular, Inhalation, Nasal, Injectable, Topical, and Others), By Application (Cardiovascular, Diabetes, Cancer, Infectious Diseases, and Others), By End User (Hospitals, Ambulatory Services, and Home Healthcare), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) – Market Forecast Till 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Drug Delivery Devices Market Infographic
    Purchase Options

    US Drug Delivery Devices Market Summary

    The US Injectable Drug Delivery Devices market is projected to grow from 45.67 USD Billion in 2024 to 78.9 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    US Injectable Drug Delivery Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.1% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 78.9 USD Billion, indicating substantial growth potential.
    • In 2024, the market is valued at 45.67 USD Billion, laying a strong foundation for future expansion.
    • Growing adoption of advanced drug delivery technologies due to increasing demand for patient-friendly administration methods is a major market driver.

    Market Size & Forecast

    2024 Market Size 45.67 (USD Billion)
    2035 Market Size 78.9 (USD Billion)
    CAGR (2025 - 2035) 5.1%

    Major Players

    Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Meta Platforms Inc (US), Tesla Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

    Key Companies in the US Drug Delivery Devices Market market include

    Report Scope

    Report Attribute/Metric Details
    Market Size 2022 USD 17.5 billion
    Market Size 2023 USD 19.53 billion
    Market Size 2030 USD 37.73 billion
    Compound Annual Growth Rate (CAGR) 11.6% (2023-2030)
    Base Year 2022
    Market Forecast Period 2023-2030
    Historical Data 2018 - 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Devices, Therapeutic Application, Site of Delivery and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Eisai Co. Ltd, Antares Pharma, AstraZeneca, Becton, Dickinson and Company, Eli Lilly and Company.
    Key Market Opportunities Growing awareness of vaccination in third-world countries
    Key Market Dynamics Rapid increase in demand of medical equipment.

    FAQs

    What is the expected market size of the US Drug Delivery Devices Market in 2024?

    The US Drug Delivery Devices Market is expected to be valued at 11.79 USD Billion in 2024.

    What is the projected market value for the US Drug Delivery Devices Market by 2035?

    By 2035, the US Drug Delivery Devices Market is projected to reach a value of 20.92 USD Billion.

    What is the expected CAGR for the US Drug Delivery Devices Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 5.349% from 2025 to 2035.

    Which drug delivery route is expected to be the largest segment in 2024?

    The injectable drug delivery route is expected to be the largest segment, valued at 4.0 USD Billion in 2024.

    How much is the oral drug delivery segment expected to grow by 2035?

    The oral drug delivery segment is expected to grow to 5.4 USD Billion by 2035.

    What are the major players in the US Drug Delivery Devices Market?

    Key players in the market include Teleflex, Novartis, Smiths Medical, and Medtronic among others.

    What is the market value of the transdermal drug delivery segment in 2024?

    The transdermal drug delivery segment is valued at 2.5 USD Billion in 2024.

    What is the projected market size for the inhalation delivery route by 2035?

    The inhalation drug delivery route is projected to reach a market size of 2.7 USD Billion by 2035.

    Are there any emerging trends in the US Drug Delivery Devices Market?

    Emerging trends include increased demand for innovative and convenient drug delivery solutions.

    How much is the implantable drug delivery segment expected to be valued in 2035?

    The implantable drug delivery segment is expected to be valued at 1.12 USD Billion in 2035.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials